Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Better Outcome in Children Compared to AYAs and Young Adults after Allogeneic HSCT for AML: A Multicenter Retrospective Study from the Societe Francophone De Greffe De Moelle Et De Therapie Cellulaire (SFGM -TC)

Cecile Pochon, MD, Marie Y Detrait, MD, Jean-Hugues Dalle, MD PhD, Gerard Michel, MD, Mauricette Michallet, MD PhD, Yves Bertrand, MD, Didier Blaise, Ibrahim Yakoub-Agha, MD PhD, Jacques-Olivier Bay, MD PhD, Mohamad Mohty, MD PhD, Noel-Jean Milpied, MD, Patrice Chevallier, MD, Ali Bazarbachi, MD PhD, Yves Chalandon, MD PhD, Yves Beguin, MD PhD, Stephanie Ngoc Nguyen, Regis Peffault De Latour, Eliane Albuisson, Marie Thérèse Rubio, MD

Blood (2018) 132 (Supplement 1): 3449.

https://doi.org/10.1182/blood-2018-99-110209

Published: 2018

Journal Articles

Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study

Marie Y Detrait, MD, Stéphane Morisset, Stat, Anne Beatrice Notarantonio, Pochon Cecile, Sabine Cohen, Catherine Rioufol, PharmD, Gabrielle Roth Guepin, Maud D'Aveni, Adele Dhuyser, Sylvie Tarillon, Chapel Valerie, Marie t Rubio, MDPhD, Barraco Fiorenza, Mauricette Michallet, MD PhD

Blood (2016) 128 (22): 5749.

https://doi.org/10.1182/blood.V128.22.5749.5749

Published: 2016

Journal Articles

CloB2A2 Reduced-Intensity Conditioning (RIC) Regimen Prior to Allogeneic Stem Cell Transplantation Provides Significant Better Survival Compared to FB2A2 RIC Regimen in Adults with Acute Myeloid Leukemia (AML): A Study on Behalf of the SFGM-TC

Blood (2015) 126 (23): 1908.

https://doi.org/10.1182/blood.V126.23.1908.1908

Published: 2015

Journal Articles

Flamsa Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation for High Risk Acute Myeloid Leukemia Patients

Mauricette Michallet, MD PhD, Mohamad Sobh, Pharm.M., Marie Y. Detrait, MD, Helene Labussiere-Wallet, MD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Mohamed Elhamri, PhD, Lila Gilis, MD, Laure L Lebras, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Valentina Bozzoli, MD, Franck E. Nicolini, MD PhD, Xavier Thomas, MD PhD

Blood (2014) 124 (21): 3892.

https://doi.org/10.1182/blood.V124.21.3892.3892

Published: 2014

Journal Articles

Prospective Qualitative Study Concerning the Efficiency of PBSC Collections after a Change of Apheresis Device

Marie Y. Detrait, MD, Stephane Morisset, Stat., Jean-Pierre Delville, Arnaud Lixon, Julie Boul, Jean-François Colot, Sabine Meurisse, Odile Bocahut, Philippe Mineur, MD, Margareta Nedelcu, Delphine Pranger, Julien Depaus, Carmela Piacentini, Maryvonne Jurdan, MD, Anne Kornreich, MD, Jean-Luc Canon

Blood (2014) 124 (21): 5834.

https://doi.org/10.1182/blood.V124.21.5834.5834

Published: 2014

Journal Articles

Invasive Pulmonary Aspergillosis in AML and ALL Patients Hospitalized into an Intensive Care Unit Divided into 2 Areas with a Different Specific Air Environment: Evaluation of Posaconazole Prophylaxis and Comparison Between the Two Specific Air Environment Areas

Marie Y. Detrait, MD, Stephane Morisset, Stat., Jean-Pierre Delville, Arnaud Lixon, Sabine Meurisse, Xavier Holemans, Nathalie De Visscher, Philippe Mineur, MD, Delphine Pranger, Margareta Nedelcu, Julien Depaus, Martin Di Biase, Celine Van Wetter, Francoise Anckaert, Anne Kornreich, MD, Jean-Luc Canon

Blood (2014) 124 (21): 5260.

https://doi.org/10.1182/blood.V124.21.5260.5260

Published: 2014

Journal Articles

Prophylactic Extracorporeal Photopheresis for Gvhd Prevention after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation from Identical Siblings and 10/10 HLA Unrelated Hematopoietic Stem Cells Donors

Mauricette Michallet, MD PhD, Mohamad Sobh, Pharm.M., Aline Praire, MSc, Frederic Garban, MD PhD, Claude Eric Bulabois, MD, Ibrahim Yakoub-Agha, MD PhD, Valerie Coiteux, MD, Remy Dulery, MD, Pierre-Simon Rohrlich, MDPhD, Faezeh Legrand, MD, Laurence Clement, Stephane Morisset, Stat., Giovanna Cannas, MD, Marie Y. Detrait, MD, Fiorenza Barraco, MD, Franck E. Nicolini, MD PhD, Olivier Hequet, MD

Blood (2014) 124 (21): 3916.

https://doi.org/10.1182/blood.V124.21.3916.3916

Published: 2014

Journal Articles

Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot Study

Marie Y. Detrait, MD, Stephane Morisset, Sabine Cohen, Monique Manchon, Verane Schwiertz, Florence Ranchon, Nicolas Vantard, Caroline Serrier, MD, Adrien Quintela, Christiane Cazac, Carole Hospital, Valerie Chapel, Sothiny Sar, Catherine Rioufol, Mauricette Michallet, MD, PhD, Fiorenza Barraco, MD

Blood (2013) 122 (21): 4549.

https://doi.org/10.1182/blood.V122.21.4549.4549

Published: 2013

Journal Articles

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Felipe Suarez, MD, Philippe Bourget, PhD, Emilio Paolo Alessandrino, MD, Mario Regazzi, PhD, Gérard Socié, MD, PhD, Mauricette Michallet, MD, PhD, Jérôme Guitton, PHD, Sebastien Wittnebel, MD, Angelo Paci, PHD, Didier Blaise, MD, Bénédicte Devictor, PHD, Ana Berceanu, MD, Véronique Kemmel, PHD, Jorge Sierra, MD, PhD, Maria Estela Moreno Martinez, PHD, Ambroise Marcais, MD, Alexandre Amin, PHD, Anna Amelia Colombo, MD, Francesco Ripamonti, MD, de Latour Régis Peffault, MD, Nathalie Dhedin, MD, Alienor Xhaard, MD, Hélène Labussière-Wallet, MD, Franck E Nicolini, MD, PhD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Xavier Thomas, MD, Jean-Henri Bourhis, MD, PhD, Gonzalo Ferrini, PHD, Sabine Furst, MD, Bruno Lioure, MD, Rodrigo Martino, MD, PhD, Mireia Riba, PH, Anna Feliu, PHD, Carole Levrault, Marcello Riggi, MD, PhD, Christine Ta Thanh Minh, MD

Blood (2013) 122 (21): 4566.

https://doi.org/10.1182/blood.V122.21.4566.4566

Published: 2013

Journal Articles

Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation For High Risk Acute Myeloid Leukemia Patients In First Complete Remission: A Prospective Pilot Study

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Marie Y. Detrait, MD, Helene Labussiere, MD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Mohamed El Hamri, PhD, Lila Gilis, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Valentina Bozzoli, MD, Franck E. Nicolini, MD, PhD, Xavier Thomas, MD

Blood (2013) 122 (21): 2162.

https://doi.org/10.1182/blood.V122.21.2162.2162

Published: 2013

Journal Articles

Significant Impact Of Iron Chelation After Allogeneic Hematopoetic Stem Cell Transplantation On Disease Recurrence: Potential Anti-Leukemic Activity

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Lila Gilis, MD, Richard Cohen, Tech., Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Colette Chapuis-Cellier, MD

Blood (2013) 122 (21): 180.

https://doi.org/10.1182/blood.V122.21.180.180

Published: 2013

Journal Articles

Phase II Prospective Multicentre Study Testing The Efficacy and Safety Of a Clofarabine (Clo), I.v. Busulfan (Bu) and Antithymocyte Globulins (ATG)-Based Reduced-Intensity Conditioning Regimen (RIC) Before Allogeneic Stem Cell Transplantation (allo-SCT) For High-Risk Myelodysplastic Syndrome Or Acute Leukemia: The Cloric Trial

Patrice Chevallier, MD, PHD, Myriam Labopin, MD, Gérard Socié, MD, PhD, Stephane Vigouroux, MD, Sabine Furst, MD, Marie Y. Detrait, MD, Bruno Lioure, MD, Thierry Guillaume, MD, Jacques Delaunay, MD, Regis Peffault de la Tour, MD, PhD, Noel Milpied, MD, PhD, Didier Blaise, Mauricette Michallet, MD, PhD, Karin Bilger, MD, Philippe Moreau, MD, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 413.

https://doi.org/10.1182/blood.V122.21.413.413

Published: 2013

Journal Articles

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Valéerie Dubois, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sylvie Rey, Isabelle Mollet, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 604.

https://doi.org/10.1182/blood.V120.21.604.604

Published: 2012

Journal Articles

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Marie Y. Detrait, MD, Ibrahim Yakoub-Agha, MD, PhD, Valerie Dubois, MD, Françoise Dufossé, Myriam Labalette, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Nathalie Tedone, CRA, Sylvie Rey, Elodie Morais, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 4540.

https://doi.org/10.1182/blood.V120.21.4540.4540

Published: 2012

Journal Articles

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Blood (2012) 120 (21): 4549.

https://doi.org/10.1182/blood.V120.21.4549.4549

Published: 2012

Journal Articles

Iron Overload in Patients with Hematological Disorders Undergoing Allogeneic HSCT: Unrevealed Implication in Different Outcomes

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Anne Cordonnier, Richard Cohen, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Colette Chapuis-Cellier, MD

Blood (2012) 120 (21): 4527.

https://doi.org/10.1182/blood.V120.21.4527.4527

Published: 2012

Journal Articles

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Marie Y. Detrait, MD, Roberto Crocchiolo, MD PhD, Stephane Vigouroux, MD, Jacques-Olivier Bay, MD, PhD, Mohamad Sobh, Pharm.M., Fiorenza Barraco, MD, Stéphane Morisset, Stat., Reza Tabrizi, MD, Nicole Raus, Regis Peffault de la Tour, Gérard Socié, MD PhD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, MD PhD, Noel Milpied, MD, Didier Blaise, MD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 1947.

https://doi.org/10.1182/blood.V120.21.1947.1947

Published: 2012

Journal Articles

High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Valerie Dubois, MD, Jean-Paul Bourgeot, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Valerie Mialou, Valérie Chapelle, Sothiny Sar, Olivier Hequet, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Yves Bertrand

Blood (2012) 120 (21): 1992.

https://doi.org/10.1182/blood.V120.21.1992.1992

Published: 2012

Journal Articles

MMR and CMR in Chronic Phase Chronic Myeloid Leukemia Patients: Role of Sokal Score and Different Tyrosine Kinase Inhibitors On Time of Their Obtention, Maintenance and Failure-Free Survival

Mauricette Michallet, MD, PhD, Hélène Labussière-Wallet, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Madeleine Etienne, CRA, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Xavier Thomas, MD, Oriane Le Borgne, CRA, Isabelle Tigaud, MD, Sandrine Hayette, Franck E. Nicolini, MD, PhD

Blood (2012) 120 (21): 4437.

https://doi.org/10.1182/blood.V120.21.4437.4437

Published: 2012

Journal Articles

Azacitidine Use in MDS and AML Patients: Best Selection for Better Results

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm. M., Stéphane Morisset, Stat., Carine Champigneulle, CRA, Florence Ranchon, Marie Y. Detrait, MD, Hélène Labussière-Wallet, MD, Sophie Ducastelle, MD, Franck E. Nicolini, MD, PhD, Youcef Chelghoum, MD, Xavier Thomas, MD, Caroline Le jeune, MD, Eric Wattel, MD, PhD, Catherine Rioufol, PharmD, Fiorenza Barraco, MD

Blood (2012) 120 (21): 5070.

https://doi.org/10.1182/blood.V120.21.5070.5070

Published: 2012

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Better Outcome in Children Compared to AYAs and Young Adults after Allogeneic HSCT for AML: A Multicenter Retrospective Study from the Societe Francophone De Greffe De Moelle Et De Therapie Cellulaire (SFGM -TC)

Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study

CloB2A2 Reduced-Intensity Conditioning (RIC) Regimen Prior to Allogeneic Stem Cell Transplantation Provides Significant Better Survival Compared to FB2A2 RIC Regimen in Adults with Acute Myeloid Leukemia (AML): A Study on Behalf of the SFGM-TC

Flamsa Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation for High Risk Acute Myeloid Leukemia Patients

Prospective Qualitative Study Concerning the Efficiency of PBSC Collections after a Change of Apheresis Device

Invasive Pulmonary Aspergillosis in AML and ALL Patients Hospitalized into an Intensive Care Unit Divided into 2 Areas with a Different Specific Air Environment: Evaluation of Posaconazole Prophylaxis and Comparison Between the Two Specific Air Environment Areas

Prophylactic Extracorporeal Photopheresis for Gvhd Prevention after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation from Identical Siblings and 10/10 HLA Unrelated Hematopoietic Stem Cells Donors

Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot Study

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation For High Risk Acute Myeloid Leukemia Patients In First Complete Remission: A Prospective Pilot Study

Significant Impact Of Iron Chelation After Allogeneic Hematopoetic Stem Cell Transplantation On Disease Recurrence: Potential Anti-Leukemic Activity

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Iron Overload in Patients with Hematological Disorders Undergoing Allogeneic HSCT: Unrevealed Implication in Different Outcomes

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies

MMR and CMR in Chronic Phase Chronic Myeloid Leukemia Patients: Role of Sokal Score and Different Tyrosine Kinase Inhibitors On Time of Their Obtention, Maintenance and Failure-Free Survival

Azacitidine Use in MDS and AML Patients: Best Selection for Better Results

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only